Similar articles for PMID: 29419476

Year	Number of Results
2000	1
2002	1
2003	2
2004	3
2005	2
2006	5
2007	9
2008	8
2009	3
2010	3
2011	4
2013	6
2014	4
2015	6
2016	5
2017	9
2018	6
2024	0

1

Reply: Staging, Restaging, and Treatment Response Assessment in Lymphomas: What We Should Know.

Delgado-Bolton R, Esposito G, Colletti PM, Jadvar H. Delgado-Bolton R, et al. J Nucl Med. 2018 Apr;59(4):715-716. doi: 10.2967/jnumed.117.206946. Epub 2018 Feb 1. J Nucl Med. 2018. PMID: 29419476 Free article. No abstract available.

2

Staging, Restaging, and Treatment Response Assessment in Lymphomas: What We Should Know.

Kanoun S, Cottereau AS, Berriolo-Riedinger A, Meignan M, Casasnovas O, Courbon F, Kraeber-Bodéré F. Kanoun S, et al. J Nucl Med. 2018 Apr;59(4):714-715. doi: 10.2967/jnumed.117.205351. Epub 2017 Dec 21. J Nucl Med. 2018. PMID: 29269571 Free article. No abstract available.

3

[Clinical experience in using 18F-FDG PET in the staging and restaging of malignant lymphomas].

Tlostanova MS, Tiutin LA, Ryzhkova DV, Il'in NV, Ivanova EI, Vinogradova IuN, Ivanova AA, Savchenko ON. Tlostanova MS, et al. Vestn Rentgenol Radiol. 2008 Jan-Feb;(1):50-3. Vestn Rentgenol Radiol. 2008. PMID: 22187900 Russian.

4

[(18)F]FDG in childhood lymphoma: clinical utility and impact on management.

Montravers F, McNamara D, Landman-Parker J, Grahek D, Kerrou K, Younsi N, Wioland M, Leverger G, Talbot JN. Montravers F, et al. Eur J Nucl Med Mol Imaging. 2002 Sep;29(9):1155-65. doi: 10.1007/s00259-002-0861-y. Epub 2002 Jun 25. Eur J Nucl Med Mol Imaging. 2002. PMID: 12192560

5

PET Scans for Staging and Restaging in Diffuse Large B-Cell and Follicular Lymphomas.

Barrington SF, Mikhaeel NG. Barrington SF, et al. Curr Hematol Malig Rep. 2016 Jun;11(3):185-95. doi: 10.1007/s11899-016-0318-1. Curr Hematol Malig Rep. 2016. PMID: 27095319 Free PMC article. Review.

6

The role of 18F-FDG PET/CT in staging and restaging primary bone lymphoma.

Liu Y. Liu Y. Nucl Med Commun. 2017 Apr;38(4):319-324. doi: 10.1097/MNM.0000000000000652. Nucl Med Commun. 2017. PMID: 28225435

7

Haematological cancer: Staging and restaging patients with lymphoma - a better approach?

Bhatt VR, Armitage JO. Bhatt VR, et al. Nat Rev Clin Oncol. 2017 Sep;14(9):527-528. doi: 10.1038/nrclinonc.2017.81. Epub 2017 Jun 20. Nat Rev Clin Oncol. 2017. PMID: 28631736 No abstract available.

8

PET/computed tomography and lymphoma.

Allen-Auerbach M, de Vos S, Czernin J. Allen-Auerbach M, et al. Radiol Clin North Am. 2013 Sep;51(5):833-44. doi: 10.1016/j.rcl.2013.05.004. Epub 2013 Jul 9. Radiol Clin North Am. 2013. PMID: 24010908 Review.

9

18F-FDG-PET in patients with malignant lymphoma having long-term follow-up: staging and restaging, and evaluation of treatment response and recurrence.

Isohashi K, Tatsumi M, Higuchi I, Inoue A, Nakajo K, Ishikawa J, Shimosegawa E, Kanakura Y, Nakamura H, Hatazawa J. Isohashi K, et al. Ann Nucl Med. 2008 Nov;22(9):795-802. doi: 10.1007/s12149-008-0186-4. Epub 2008 Nov 28. Ann Nucl Med. 2008. PMID: 19039558

10

Staging/restaging performance of F18-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in breast cancer: A review and meta-analysis.

Lin CY, Lin CL, Kao CH. Lin CY, et al. Eur J Radiol. 2018 Oct;107:158-165. doi: 10.1016/j.ejrad.2018.09.003. Epub 2018 Sep 5. Eur J Radiol. 2018. PMID: 30292261

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

72 results

Results by year